VEGFA and diabetic kidney disease: Although several studies, including ours, have shown that PAR2 exacerbates glomerular injury in models of diabetic kidney disease (DKD) or glomerulonephritis7,8, the role of PAR2 in VEGF inhibitor-induced kidney injury is controversial.